Signos Secures 20M in Funding to Expand AIPowered Glucose Monitoring for Weight Loss Evercore ISI Lowers Price Target on Illinois Tool Works ITW Amid Revised Outlook Singapores MAS Aims to Accelerate Private Banking Account Openings to Under One Month Fed Dissenters Kashkari Logan Hammack Explain Opposition to Rate Cut Signal ATTs Talent Hunt Highlights Shift BlueCollar Workers May Be the Winners in AI Economy Kotak Mahindra Bank Shares Recent Market Performance and Investor Sentiment Equity Lifestyle Properties Inc ELS Q1 2026 Earnings Modest EPS Beat Amid Stable Operations CNX Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds GDEV Q4 2025 Earnings EPS Misses Estimates Shares Decline Life Time Group Holdings LTH Q1 2026 Earnings EPS Beats Estimates as Membership Trends Strengthen Stock Slips NE Q1 2026 Earnings EPS Beats Estimates by 301 Stock Declines Kaltura Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency Telesat Corporation TSAT Rises 123 as Stock Approaches Key Resistance Near 6144 Essent Group Ltd ESNT Dips 19 as Shares Test Key Support Levels Sprott Focus Trust Inc FUND Edges Higher as Precious Metals Fund Holds Near Key Support Wing Yip Food Holdings Group WYHG Slips 49 as Support Levels Near Consolidation Phase HealthStream Inc HSTM Edges Higher Amid Consolidation Near Resistance Geopolitical Tensions in Middle East Weigh on Asian Currencies as Oil Prices and US Dollar Surge ICU Medical ICUI Q1 2026 Earnings Strong EPS Beat Lifts Shares as Medical Device Demand Holds WhiteHorse Finance WHF Stock Slips Amid Narrow Trading Range Key Support and Resistance Levels in Focus Vishay Intertechnology Q1 2026 Earnings EPS Surprises to the Upside Amid Revenue Disclosure Absence VEEE Q2 2025 Earnings Narrower Loss Propels Stock Higher Amid Strategic Transition REZI Q1 2026 Earnings EPS Beats Estimates Stock Gains 4 NVDA Q1 2026 Earnings Strong EPS Beat Amid Market Caution MCO Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist WATT Q1 2026 Earnings EPS Surprise of 3464 Despite No Revenue Stock Declines